Cytokine Market Growth | Trends, Size, Share & Forecast 2025 | Top key players - AbbVie Inc, Sanofi, Novartis AG.

The Global Cytokine Market reached US$ 72.3 billion in 2022 and is expected to reach US$ 132.2 billion by 2030, growing with a CAGR of 7.6 % during the forecast period 2024-2031.

Cytokine Market report, published by DataM Intelligence, delivers detailed insights and analysis on major market trends, growth prospects, and emerging challenges. With a strong focus on providing actionable intelligence, DataM Intelligence enables businesses to make well-informed decisions and maintain a competitive edge. By blending both qualitative and quantitative research approaches, the company offers thorough reports that support clients in navigating complex market environments, driving strategic expansion, and capitalizing on new opportunities in today's rapidly evolving global landscape.

The Cytokine Market involves the production, development, and application of small proteins that help regulate immunity, inflammation, and cell signaling. These biologics are widely used in treating cancer, autoimmune disorders, and infectious diseases. Growing research in immunotherapy and advancements in biotechnology are driving market growth, making cytokines vital tools in modern medical treatments and diagnostics.

Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/cytokine-market?sz

Market opportunities and Growth Drivers:

The Advancement of New Technologies

Cytokines continue to play a vital role in the field of cancer immunotherapy, showing promising potential in cancer treatment. These powerful signaling proteins have already been used successfully to treat various forms of cancer, as well as viral infections like hepatitis B and C. Cytokines are also effective in managing certain rare genetic disorders.

What makes cytokines especially valuable is their ability to support the immune system by responding to inflammation and infection-mechanisms that can help suppress tumor growth. As a result, their therapeutic application in oncology is expected to dominate the market, contributing the largest share over the forecast period.

Cytokine Market Recent Development:

In March 2023, the U.S. FDA approved CLN-617, a novel fusion protein developed by Cullinan Oncology, Inc., for a Phase 1 clinical trial. CLN-617 combines IL-2 and IL-12 cytokines with a collagen-binding domain, designed to retain the therapeutic protein in the tumor microenvironment (TME) after intratumoral injection. The trial targets advanced solid tumors, marking a step forward in cytokine-based immunotherapy.

In June 2023, Genentech (a Roche Group member) received FDA approval for Columvi (glofitamab-gxbm), a bispecific antibody, for treating adult patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) or large B-cell lymphoma (LBCL) arising from follicular lymphoma, after two or more prior systemic therapies. This expands treatment options for patients with aggressive forms of non-Hodgkin lymphoma.

List of the Key Players in the Cytokine Market:

CytoAgents, Cullinan Oncology, Inc, Genentech, Inc, AbbVie Inc, Sanofi, Novartis AG, Pfizer Inc, F. Hoffmann-La Roche Ltd , Merck KGaA, GenScript and among others.

Research Process:

Both primary and secondary data sources have been used in the global Cytokine Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/cytokine-market

Segment Covered in the Cytokine Market:

By Type: Chemokines, Interferons, Interleukins, Tumor necrosis factor (TNF), Monokines, Lymphokines, Colony-stimulating factors (CSF).

By Application: Cancer, Orthopedic, Dermatology, Others.

By End Users: Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Research Institutes, Others.

Regional Analysis for Cytokine Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

People Also Ask:

Most Frequently Asked Questions in the Cytokine Market Research Industry:

➠ What are the global figures for sales, production, consumption, imports, and exports in the Cytokine market?

➠ Who are the top manufacturers in the global Cytokine industry, and what is their current status in terms of production capacity, output, sales performance, pricing structure, cost analysis, profit margins, and overall revenue?

➠ What key opportunities are available for vendors in the Cytokine market, and what challenges are they likely to encounter?

➠ Which application areas, end-user segments, or product types are projected to experience significant growth, and how is the market share distributed among them?

➠ What are the major drivers and barriers influencing the growth trajectory of the Cytokine market?

➠ What are the primary sales, marketing, and distribution strategies used across the global Cytokine industry landscape?

Browse More Reports: https://www.datamintelligence.com/research-report/cytokine-market

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.